268 related articles for article (PubMed ID: 34387765)
1. PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 Trial.
Raoof M; Malhotra G; Kohut A; O'Leary M; Frankel P; Tran T; Fakih M; Chao J; Lim D; Woo Y; Paz IB; Lew M; Cristea MC; Rodriguez-Rodriguez L; Fong Y; Blakely A; Whelan R; Reymond MA; Merchea A; Dellinger TH
Ann Surg Oncol; 2022 Jan; 29(1):175-185. PubMed ID: 34387765
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA.
Raoof M; Whelan RL; Sullivan KM; Ruel C; Frankel PH; Cole SE; Tinsley R; Eng M; Fakih M; Chao J; Lim D; Woo Y; Paz IB; Lew M; Cristea M; Rodriguez-Rodriguez L; Fong Y; Thomas RM; Chang S; Deperalta D; Merchea A; Dellinger TH
Ann Surg Oncol; 2023 Nov; 30(12):7814-7824. PubMed ID: 37501051
[TBL] [Abstract][Full Text] [Related]
3. Multicenter dose-escalation Phase I trial of mitomycin C pressurized intraperitoneal aerosolized chemotherapy in combination with systemic chemotherapy for appendiceal and colorectal peritoneal metastases: rationale and design.
Raoof M; Sullivan KM; Frankel PH; Fakih M; Synold TW; Lim D; Woo Y; Paz IB; Fong Y; Thomas RM; Chang S; Eng M; Tinsley R; Whelan RL; Deperalta D; Reymond MA; Jones J; Merchea A; Dellinger TH
Pleura Peritoneum; 2022 Dec; 7(4):169-177. PubMed ID: 36560966
[TBL] [Abstract][Full Text] [Related]
4. Phase I/II study of oxaliplatin dose escalation via a laparoscopic approach using pressurized aerosol intraperitoneal chemotherapy (PIPOX trial) for nonresectable peritoneal metastases of digestive cancers (stomach, small bowel and colorectal): Rationale and design.
Dumont F; Senellart H; Pein F; Campion L; Glehen O; Goere D; Pocard M; Thibaudeau E
Pleura Peritoneum; 2018 Sep; 3(3):20180120. PubMed ID: 30911664
[TBL] [Abstract][Full Text] [Related]
5. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in combination with FOLFOX chemotherapy as a first-line treatment for gastric cancer patients with peritoneal metastases: single-arm phase II study.
Luksta M; Bausys A; Bickaite K; Rackauskas R; Paskonis M; Luksaite-Lukste R; Ranceva A; Stulpinas R; Brasiuniene B; Baltruskeviciene E; Lachej N; Sabaliauskaite R; Bausys R; Tulyte S; Strupas K
BMC Cancer; 2023 Oct; 23(1):1032. PubMed ID: 37875869
[TBL] [Abstract][Full Text] [Related]
6. Initial experience of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a French hyperthermic intraperitoneal chemotherapy (HIPEC) expert center.
Ceribelli C; Debs T; Chevallier A; Piche MA; Bereder JM
Surg Endosc; 2020 Jun; 34(6):2803-2806. PubMed ID: 32166545
[TBL] [Abstract][Full Text] [Related]
7. Unresectable peritoneal metastasis treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC) leading to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Alyami M; Mercier F; Siebert M; Bonnot PE; Laplace N; Villeneuve L; Passot G; Glehen O; Bakrin N; Kepenekian V
Eur J Surg Oncol; 2021 Jan; 47(1):128-133. PubMed ID: 31253545
[TBL] [Abstract][Full Text] [Related]
8. Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study.
Nowacki M; Alyami M; Villeneuve L; Mercier F; Hubner M; Willaert W; Ceelen W; Reymond M; Pezet D; Arvieux C; Khomyakov V; Lay L; Gianni S; Zegarski W; Bakrin N; Glehen O
Eur J Surg Oncol; 2018 Jul; 44(7):991-996. PubMed ID: 29526367
[TBL] [Abstract][Full Text] [Related]
9. PIPAC-OX: A Phase I Study of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy in Patients with Peritoneal Metastases.
Kim G; Tan HL; Sundar R; Lieske B; Chee CE; Ho J; Shabbir A; Babak MV; Ang WH; Goh BC; Yong WP; Wang L; So JBY
Clin Cancer Res; 2021 Apr; 27(7):1875-1881. PubMed ID: 33148667
[TBL] [Abstract][Full Text] [Related]
10. PIPAC EstoK 01: Pressurized IntraPeritoneal Aerosol Chemotherapy with cisplatin and doxorubicin (PIPAC C/D) in gastric peritoneal metastasis: a randomized and multicenter phase II study.
Eveno C; Jouvin I; Pocard M
Pleura Peritoneum; 2018 Jun; 3(2):20180116. PubMed ID: 30911659
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Peritoneal Metastasis with Pressurized Intraperitoneal Aerosol Chemotherapy: Results from the Prospective PIPAC-OPC2 Study.
Graversen M; Detlefsen S; Ainsworth AP; Fristrup CW; Knudsen AO; Pfeiffer P; Tarpgaard LS; Mortensen MB
Ann Surg Oncol; 2023 May; 30(5):2634-2644. PubMed ID: 36602663
[TBL] [Abstract][Full Text] [Related]
12. Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis.
Robella M; Vaira M; De Simone M
World J Surg Oncol; 2016 Apr; 14():128. PubMed ID: 27125996
[TBL] [Abstract][Full Text] [Related]
13. PIPAC for Gastrointestinal Malignancies.
Daniel SK; Sun BJ; Lee B
J Clin Med; 2023 Oct; 12(21):. PubMed ID: 37959264
[TBL] [Abstract][Full Text] [Related]
14. Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC).
Rovers KP; Lurvink RJ; Wassenaar EC; Kootstra TJ; Scholten HJ; Tajzai R; Deenen MJ; Nederend J; Lahaye MJ; Huysentruyt CJ; van 't Erve I; Fijneman RJ; Constantinides A; Kranenburg O; Los M; Thijs AM; Creemers GM; Burger JW; Wiezer MJ; Boerma D; Nienhuijs SW; de Hingh IH
BMJ Open; 2019 Jul; 9(7):e030408. PubMed ID: 31352425
[TBL] [Abstract][Full Text] [Related]
15. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer.
Alyami M; Bonnot PE; Mercier F; Laplace N; Villeneuve L; Passot G; Bakrin N; Kepenekian V; Glehen O
Eur J Surg Oncol; 2021 Jan; 47(1):123-127. PubMed ID: 32561204
[TBL] [Abstract][Full Text] [Related]
16. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne.
Casella F; Bencivenga M; Rosati R; Fumagalli UR; Marrelli D; Pacelli F; Macrì A; Donini A; Torroni L; Pavarana M; De Manzoni G
Pleura Peritoneum; 2022 Sep; 7(3):135-141. PubMed ID: 36159218
[TBL] [Abstract][Full Text] [Related]
17. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in combination with standard of care chemotherapy in primarily untreated chemo naïve upper gi-adenocarcinomas with peritoneal seeding - a phase II/III trial of the AIO/CAOGI/ACO.
Oliver Goetze T; Al-Batran SE; Pabst U; Reymond M; Tempfer C; Bechstein WO; Bankstahl U; Gockel I; Königsrainer A; Kraus T; Mönig SP; Rau B; Schwarzbach M; Piso P
Pleura Peritoneum; 2018 Jun; 3(2):20180113. PubMed ID: 30911658
[TBL] [Abstract][Full Text] [Related]
18. Pressurized Intraperitoneal Aerosol Chemotherapy-Related Clinical Trials in the Treatment of Peritoneal Metastases.
Ukegjini K; Putora PM; Guidi M; Süveg K; Cihoric N; Widmann B; Steffen T
Oncology; 2021; 99(9):601-610. PubMed ID: 34265774
[TBL] [Abstract][Full Text] [Related]
19. Pressurized IntraPeritoneal Aerosol Chemotherapy with one minute of electrostatic precipitation (ePIPAC) is feasible, but the histological tumor response in peritoneal metastasis is insufficient.
Graversen M; Detlefsen S; Ellebaek SB; Fristrup C; Pfeiffer P; Mortensen MB
Eur J Surg Oncol; 2020 Jan; 46(1):155-159. PubMed ID: 31493986
[TBL] [Abstract][Full Text] [Related]
20. Pressurized Intraperitoneal Aerosol Chemotherapy (Oxaliplatin) for Unresectable Colorectal Peritoneal Metastases: A Multicenter, Single-Arm, Phase II Trial (CRC-PIPAC).
Rovers KP; Wassenaar ECE; Lurvink RJ; Creemers GM; Burger JWA; Los M; Huysentruyt CJR; van Lijnschoten G; Nederend J; Lahaye MJ; Deenen MJ; Wiezer MJ; Nienhuijs SW; Boerma D; de Hingh IHJT
Ann Surg Oncol; 2021 Sep; 28(9):5311-5326. PubMed ID: 33544279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]